These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Development of a new real-time PCR screening kit for HbS and common beta-thalassemia mutations observed in Turkey. Kan Karaer D; Ergün MA; Ruhi HI; Öztürk J; Kara H; Reisoğlu Çakmak D; Aydoğmuş T; Perçin EF Turk J Med Sci; 2017 Jun; 47(3):973-978. PubMed ID: 28618753 [TBL] [Abstract][Full Text] [Related]
8. Clinical Course of Patients With Sickle Cell Anemia and Co-inherited Hematological Disorders: Experience at a Tertiary Hematological Centre. Patel S; Krishnan VP; Kanvinde P; Mudaliar S; Shah N; Swami A; Desai M; Agarwal B Indian J Hematol Blood Transfus; 2020 Oct; 36(4):754-757. PubMed ID: 33100722 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of beta-thalassemia and sickle cell anemia in Antalya. Keser I; Sanlioglu AD; Manguoglu E; Guzeloglu Kayisli O; Nal N; Sargin F; Yesilipek A; Simsek M; Mendilcioglu I; Canatan D; Luleci G Acta Haematol; 2004; 111(4):205-10. PubMed ID: 15153712 [TBL] [Abstract][Full Text] [Related]
10. Interaction between HBS-beta-o-thalassemia and alpha-thalassemia. Steinberg MH; Coleman MB; Adams JG; Rosenstock W Am J Med Sci; 1984 Dec; 288(5):195-9. PubMed ID: 6083725 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive prenatal diagnosis experience in the Çukurova Region of Southern Turkey: detecting paternal mutations of sickle cell anemia and β-thalassemia in cell-free fetal DNA using high-resolution melting analysis. Yenilmez ED; Tuli A; Evrüke IC Prenat Diagn; 2013 Nov; 33(11):1054-62. PubMed ID: 23836351 [TBL] [Abstract][Full Text] [Related]
12. Two new sickle cell syndromes: HbS, Hb Camden, and alpha-thalassemia; and HbS in combination with Hb Tacoma. Honig GR; Mason RG; Shamsuddin M; Vida LN; Rao KR; Patel AR Blood; 1980 Apr; 55(4):655-60. PubMed ID: 7357091 [TBL] [Abstract][Full Text] [Related]
13. Ocular Manifestations of Sickle Cell Disease in Different Genotypes. AlRyalat SA; Jaber BAM; Alzarea AA; Alzarea AA; Alosaimi WA; Al Saad M Ophthalmic Epidemiol; 2021 Jun; 28(3):185-190. PubMed ID: 32757703 [TBL] [Abstract][Full Text] [Related]
14. [Sickle cell syndrome. Association between hemoglobin S and β thalassemia]. Gasparini NP; Agriello EE; Zanella MJ; Iommi MP; Maradei J; Sandoval MJ Medicina (B Aires); 2016; 76(6):369-372. PubMed ID: 27959846 [TBL] [Abstract][Full Text] [Related]
15. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease. Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients. Pandey H; Singh K; Ranjan R; Dass J; Tyagi S; Seth T; Saxena R; Mahapatra M J Lab Physicians; 2023 Dec; 15(4):583-589. PubMed ID: 37780888 [No Abstract] [Full Text] [Related]
17. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios. Allaf B; Patin F; Elion J; Couque N Pediatr Blood Cancer; 2018 Sep; 65(9):e27230. PubMed ID: 29781571 [TBL] [Abstract][Full Text] [Related]
18. Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience. Pandey H; Singh K; Ranjan R; Pandey SK; Sharma A; Kishor K; Seth T; Mahapatra M; Saxena R Hematology; 2019 Dec; 24(1):349-352. PubMed ID: 30777489 [TBL] [Abstract][Full Text] [Related]
19. Value of DNA testing in the diagnosis of sickle-cell anemia in childhood in an environment with a high prevalence of other causes of anemia. Mbayabo G; Lumbala Kabuyi P; Ngole M; Lumaka A; Race V; Maisin D; Gruson D; Matthijs G; Minga TM; Devriendt K; Van Geet C; Tshilobo PL J Clin Lab Anal; 2022 Aug; 36(8):e24593. PubMed ID: 35819088 [TBL] [Abstract][Full Text] [Related]
20. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia. Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]